A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels
Steven K. Libutti, H. Richard Alexander, Peter Choyke, David L. Bartlett, Stephen L. Bacharach, Millie Whatley, Frederic Jousse, William C. Eckelman, Karen Kranda, Ronald D. Neumann, Jorge A. Carrasquillo
Research output: Contribution to journal › Article › peer-review
Dive into the research topics of 'A prospective study of 2-[18F] fluoro-2-deoxy-D-glucose/positron emission tomography scan, 99mTc-labeled arcitumomab (CEA-scan), and blind second-look laparotomy for detecting colon cancer recurrence in patients with increasing carcinoembryonic antigen levels'. Together they form a unique fingerprint.